DermTech, Inc.

OTCPK:DMTK.Q 株式レポート

時価総額:US$35.0

DermTech マネジメント

マネジメント 基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権n/a
経営陣の平均在職期間2.3yrs
取締役会の平均在任期間5.3yrs

経営陣の近況

Recent updates

DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 44%

May 21
DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 44%

We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate

Mar 02
We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate

Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%

Mar 02
Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%

Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price

Dec 28
Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price

Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky

Sep 18
Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky

Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?

Jun 14
Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?

Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023

May 10
Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023

DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%

May 06
DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%

We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Jan 16
We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)

Nov 08
Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)

Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?

Oct 11
Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?

DermTech grants stock options

Oct 11

Diving Into DermTech

Sep 01

Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80

Aug 10
Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80

DermTech: Approaching An All Or Nothing Moment

Jun 13

We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Jun 04
We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

DermTech - Taking A Second Look At The Growth Thesis

Mar 31

DermTech: Adoption Headwinds And Earnings Misses

Dec 23

Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth

Dec 02
Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth

CEO(最高経営責任者

DermTech CEOがいない、あるいは彼らに関するデータがない。


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Burkhard Jansen
Presidentno dataUS$480.83kデータなし
Jeremy Teraoka
Head of Financeno dataデータなしデータなし
Steve Kunszabo
Senior Director of Investor Relationsno dataデータなしデータなし
Jennifer Eilemberg
Chief Compliance Officer2.3yrsデータなしデータなし
Loren Clarke
Chief Medical Officer3.4yrsデータなしデータなし

2.3yrs

平均在職期間

経験豊富な経営陣: DMTK.Qの経営陣は 経験豊富 であると考えられます ( 2.3年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Herman Rosenman
Independent Director5.3yrsUS$149.64k0.28%
$ 0.1
Kirk Malloy
Independent Director2.3yrsUS$136.64k0.094%
$ 0.03
Matthew Posard
Independent Chairman of the Board8.3yrsUS$188.64k0.35%
$ 0.1
Mark Capone
Independent Director2.3yrsUS$139.64k0.081%
$ 0.03
Cynthia Collins
Independent Director5.3yrsUS$156.64k0.20%
$ 0.07
Daniel Siegel
Member of Clinical Advisory Board7.1yrsデータなしデータなし
Neal Bhatia
Member of Clinical Advisory Boardno dataデータなしデータなし
Nathalie Keraudy
Independent Director3.1yrsUS$134.64k0.092%
$ 0.03
Laura Ferris
Member of Clinical Advisory Boardno dataデータなしデータなし
Maral Skelsey
Member of Clinical Advisory Board5.8yrsデータなしデータなし
Mark Kaufmann
Member of Clinical Advisory Boardno dataデータなしデータなし
Lorraine Rosamilia
Member of Clinical Advisory Boardno dataデータなしデータなし

5.3yrs

平均在職期間

62yo

平均年齢

経験豊富なボード: DMTK.Qの 取締役会経験豊富 であると考えられます ( 5.3年の平均在任期間)。